QuidelOrtho logged a 5.0% change during today's afternoon session, and is now trading at a price of $80.42 per share. The S&P 500 index moved -0.0%. QDEL's trading volume is 393,143 compared to the stock's average volume of 440,670.
QuidelOrtho trades -31.59% away from its average analyst target price of $117.57 per share. The 7 analysts following the stock have set target prices ranging from $81.0 to $168.0, and on average have given QuidelOrtho a rating of buy.
Anyone interested in buying QDEL should be aware of the facts below:
-
QuidelOrtho's current price is -34.4% below its Graham number of $122.67, which implies the stock has a margin of safety
-
QuidelOrtho has moved -5.0% over the last year, and the S&P 500 logged a change of 8.0%
-
Based on its trailing earnings per share of -1.06, QuidelOrtho has a trailing 12 month Price to Earnings (P/E) ratio of -75.9 while the S&P 500 average is 15.97
-
QDEL has a forward P/E ratio of 14.7 based on its forward 12 month price to earnings (EPS) of $5.48 per share
-
The company has a price to earnings growth (PEG) ratio of 2.09 — a number near or below 1 signifying that QuidelOrtho is fairly valued compared to its estimated growth potential
-
Its Price to Book (P/B) ratio is 1.07 compared to its sector average of 4.16
-
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies and solutions.
-
Based in San Diego, the company has 7,000 full time employees and a market cap of $5.37 Billion.